Tamarack Valley Energy Ltd. (TSX:TVE)

Ligand Pharmaceuticals Income Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,403	1,404	1,406	1,180	598.92	197.53
Revenue Growth (YoY)	-5.19%	-0.17%	19.19%	97.03%	203.20%	-42.54%
Cost of Revenue	290.83	305.44	352.03	239.28	138.31	86.42
Gross Profit	1,112	1,099	1,054	940.74	460.61	111.12
Selling, General & Admin	33.06	32.71	31.36	27.71	18.14	11.18
Other Operating Expenses	28.83	75.88	7.83	44.06	78.94	-26.87
Operating Expenses	655.39	714.17	683.32	457.28	-74.61	509.47
Operating Income	456.54	384.53	371.12	483.46	535.22	-398.35
Interest Expense	-81.31	-90.42	-103.72	-48.59	-21.48	-9.45
Currency Exchange Gain (Loss)	0.36	0.36	-0.08	0.04	0.04	0.06
Other Non Operating Income (Expenses)	0.71	-	-	-	5.37	-1.85
EBT Excluding Unusual Items	376.31	294.47	267.31	434.91	519.14	-409.59
Merger & Restructuring Charges	-	-	-	-9.47	-8.11	-
Gain (Loss) on Sale of Assets	-38.21	-85.15	-125.95	19.25	8.74	10.67
Pretax Income	338.1	209.32	141.36	444.69	519.77	-398.93
Income Tax Expense	87.53	47.1	47.16	99.49	129.26	-87.54
Net Income	250.57	162.22	94.2	345.2	390.51	-311.38
Net Income to Common	250.57	162.22	94.2	345.2	390.51	-311.38
Net Income Growth	95.61%	72.21%	-72.71%	-11.60%	-	-
Shares Outstanding (Basic)	523	543	557	460	354	223
Shares Outstanding (Diluted)	528	547	560	464	361	223
Shares Change (YoY)	-4.97%	-2.34%	20.63%	28.69%	61.94%	-1.08%
EPS (Basic)	0.48	0.30	0.17	0.75	1.10	-1.40
EPS (Diluted)	0.48	0.30	0.17	0.74	1.08	-1.40
EPS Growth	107.77%	76.66%	-77.13%	-31.48%	-	-
Free Cash Flow	389.25	382.31	115.17	346.8	36.65	-73.17
Free Cash Flow Per Share	0.74	0.70	0.21	0.75	0.10	-0.33
Dividend Per Share	0.152	0.150	0.150	0.117	-	-
Dividend Growth	1.37%	0.33%	28.75%	-	-	-
Gross Margin	79.27%	78.25%	74.97%	79.72%	76.91%	56.25%
Operating Margin	32.55%	27.38%	26.39%	40.97%	89.36%	-201.66%
Profit Margin	17.86%	11.55%	6.70%	29.25%	65.20%	-157.64%
Free Cash Flow Margin	27.75%	27.23%	8.19%	29.39%	6.12%	-37.04%
EBITDA	1,038	978.33	1,010	868.82	825.85	122.22
EBITDA Margin	73.97%	69.67%	71.83%	73.63%	137.89%	61.87%
D&A For EBITDA	581.11	593.8	639.14	385.36	290.64	520.57
EBIT	456.54	384.53	371.12	483.46	535.22	-398.35
EBIT Margin	32.55%	27.38%	26.39%	40.97%	89.36%	-201.66%
Effective Tax Rate	25.89%	22.50%	33.36%	22.37%	24.87%	-
Revenue as Reported	1,387	1,341	1,423	1,140	524.87	224.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.